Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 0.390.410.370.350.37

What is the latest Fixed Capital/Sales ratio of WINDLAS BIOTECH ?

The latest Fixed Capital/Sales ratio of WINDLAS BIOTECH is 0.39 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20260.39
Mar20250.41
Mar20240.37
Mar20230.35
Mar20220.37

How is Fixed Capital/Sales of WINDLAS BIOTECH Trending?

Years Fixed Capital/Sales % Change
Mar2026 0.39
-4.88
Mar2025 0.41
10.81
Mar2024 0.37
5.71
Mar2023 0.35
-5.41
Mar2022 0.37 -

Other Financial Ratios of WINDLAS BIOTECH


Compare Fixed Capital/Sales ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,797.4 Cr 1.9% 5.9% -14.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹466,431.0 Cr -2.3% 3% 12.3% Stock Analytics
DIVIS LABORATORIES ₹220,115.0 Cr 2.9% 22.7% 25.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,853.0 Cr -2.7% 2% 33.9% Stock Analytics
CIPLA ₹119,158.0 Cr 0.1% 3% -7% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.4 Cr 2.4% -12.9% -9.1% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

1.9%

5.9%

-14.5%

SENSEX

1.3%

1%

-2.9%


You may also like the below Video Courses